GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology

/PRNewswire/ -- GC Biopharma Corp. (006280.KS), a leading provider of biopharmaceutical products in South Korea, announced today that it has signed an Asset...

Related Keywords

South Korea ,Eun Chul Huh ,Nassim Usman ,Rm Global Partners ,Prnewswire Gc Biopharma Corp ,Green Cross Corporation ,Asset Purchase Agreement ,Catalyst Biosciences ,Gc Biopharma ,